Pharmaceutical giant Roche, Nutley, NJ, has launched a review to choose an agency that will buy direct response media for its Tamiflu influenza pill.
Agencies participating in the review include Young & Rubicam's Impiric, which handles direct response buying for Tamiflu; Initiative Media's Media Direct Partners; and Media Marketing Solutions, also owned by Y&R.
AAR/Bob Wolf Partners, New York, is the advertising consultant on the review. The decision is due in October.
